Heid Jonas, Affolter Annette, Jakob Yvonne, Kern Johann, Rotter Nicole, Tenschert Esther, Lammert Anne
Department of Otorhinolaryngology Head and Neck Surgery, University Medical Centre Mannheim, D-68167 Mannheim, Germany.
Oncol Lett. 2022 Jun;23(6):177. doi: 10.3892/ol.2022.13297. Epub 2022 Apr 14.
Epidermal growth factor receptor (EGFR) upregulation is a typical characteristic of head and neck squamous cell carcinoma (HNSCC). However, tyrosine kinase inhibitors have not yet been able to achieve enough therapeutic benefit in clinical trials to justify their use in standard therapy regimens. At present, little is known about the reasons for this treatment failure. In the present study, the HNSCC cell lines UM-SCC-11B and UM-SCC-22B were tested for their response to tyrosine kinase inhibitors (TKI) under 2D and 3D cell culture conditions. Absorption and luciferase-based viability assays were used for this, as well as optical evaluation via fluorescence microscopy. In addition, EGFR and HER3 expression as well as the downstream signalling pathways PI3K/AKT/mTOR and RAS/RAF/MEK/ERK were investigated using western blotting. Cell line UM-SCC-11B revealed a strong resistance to lapatinib under 3D cell culture conditions, while a good response to TKI therapy was observed under 2D cell culture conditions. An associated overexpression of phosphorylated HER3 under 3D cell culture conditions offered a plausible explanation for the altered treatment response. The results of the present study represent an idea of how signalling mechanisms of cancer cells can be changed using different cell culture methods. Overall, 3D cell culture could be an important component in the analysis of resistance mechanisms in cancer therapy.
表皮生长因子受体(EGFR)上调是头颈部鳞状细胞癌(HNSCC)的典型特征。然而,酪氨酸激酶抑制剂在临床试验中尚未能够获得足够的治疗益处,无法证明其在标准治疗方案中的应用合理性。目前,对于这种治疗失败的原因知之甚少。在本研究中,对头颈部鳞状细胞癌细胞系UM-SCC-11B和UM-SCC-22B在二维和三维细胞培养条件下对酪氨酸激酶抑制剂(TKI)的反应进行了测试。为此使用了基于吸收和荧光素酶的活力测定法,以及通过荧光显微镜进行的光学评估。此外,使用蛋白质印迹法研究了EGFR和HER3的表达以及下游信号通路PI3K/AKT/mTOR和RAS/RAF/MEK/ERK。细胞系UM-SCC-11B在三维细胞培养条件下对拉帕替尼显示出强烈抗性,而在二维细胞培养条件下观察到对TKI治疗有良好反应。在三维细胞培养条件下磷酸化HER3的相关过表达为治疗反应改变提供了合理的解释。本研究结果展示了癌细胞信号传导机制如何通过不同细胞培养方法发生改变。总体而言,三维细胞培养可能是癌症治疗抗性机制分析中的一个重要组成部分。